Literature DB >> 11710930

UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model.

B Lehmann1, T Genehr, P Knuschke, J Pietzsch, M Meurer.   

Abstract

We have previously shown that keratinocytes in vitro can convert biologically inactive vitamin D3 to the hormone calcitriol (1alpha,25-dihydroxyvitamin D3). This study was initiated to test whether the ultraviolet-B-induced photolysis of provitamin D3 (7-dehydrocholesterol), which results in the formation of vitamin D3, can generate calcitriol in an in vivo-like human skin equivalent model made of fibroblasts in a collagen matrix as the dermal component and keratinocytes as the epidermal component. Cultures were preincubated with increasing concentrations of 7-dehydrocholesterol (0.53-5.94 nmol per cm2 human skin equivalent) at 37 degrees C and irradiated with monochromatic ultraviolet B at wavelengths ranging from 285 to 315 nm (effective ultraviolet doses 7.5-45 mJ per cm2). In our in vitro model irradiation with ultraviolet B resulted in a sequential metabolic process with generation of previtamin D3 followed by the time-dependent formation of vitamin D3, 25-hydroxyvitamin D3, and ultimately calcitriol in the femtomolar range. Unirradiated cultures and irradiated cultures without keratinocytes generated no calcitriol. Irradiation of skin equivalents at wavelengths > 315 nm generated no or only trace amounts of calcitriol. The ultraviolet-B-triggered conversion of 7-dehydrocholesterol to calcitriol was strongly inhibited by ketoconazole indicating the involvement of P450 mixed function oxidases. The amount of calcitriol generated was dependent on the 7-dehydrocholesterol concentration, on wavelength, and on ultraviolet B dose. Hence, keratinocytes in the presence of physiologic concentrations of 7-dehydrocholesterol and irradiated with therapeutic doses of ultraviolet B may be a potential source of biologically active calcitriol within the epidermis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710930     DOI: 10.1046/j.0022-202x.2001.01538.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  46 in total

Review 1.  [Topical treatment of psoriasis: a systematic update].

Authors:  R Aschoff; G Wozel; M Meurer
Journal:  Hautarzt       Date:  2003-02-13       Impact factor: 0.751

Review 2.  [The significance of vitamin D metabolism in human skin. An update].

Authors:  L Trémezaygues; J Reichrath
Journal:  Hautarzt       Date:  2010-06       Impact factor: 0.751

Review 3.  [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs].

Authors:  J Schmitt; M Meurer
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

Review 4.  Antimicrobial peptides and the skin immune defense system.

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  J Allergy Clin Immunol       Date:  2008-04-25       Impact factor: 10.793

5.  From the bench to emerging new clinical concepts: Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancer.

Authors:  Léa Trémezaygues; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-01

Review 6.  [Vitamin D and UV protection].

Authors:  H Stege; T Schwarz
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

7.  1,25-dihydroxyvitamin D(3) protects human keratinocytes against UV-B-induced damage: In vitro analysis of cell viability/proliferation, DNA-damage and -repair.

Authors:  Lea Trémezaygues; Markus Seifert; Wolfgang Tilgen; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2009-07

8.  UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase.

Authors:  Donald Liu; Bernadette O Fernandez; Alistair Hamilton; Ninian N Lang; Julie M C Gallagher; David E Newby; Martin Feelisch; Richard B Weller
Journal:  J Invest Dermatol       Date:  2014-01-20       Impact factor: 8.551

9.  The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial.

Authors:  M D Kearns; J N G Binongo; D Watson; J A Alvarez; D Lodin; T R Ziegler; V Tangpricha
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

Review 10.  Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.

Authors:  Jörg Reichrath; Christos C Zouboulis; Thomas Vogt; Michael F Holick
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.